Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

10 fresh takes on the lab-leak theory of COVID’s origin

Last weekend The Wall Street Journal reported on new classified intelligence that has led the U.S. Energy Department to conclude, albeit with “low confidence,” that the COVID-19 pandemic may have started in a Wuhan lab after all.

#robotassistedprocedures #interventionalprocedures

Robot-assisted needle positioning in CT-guided procedures improves accuracy, reduces repeats

Compared to freehand techniques during procedures requiring needle positioning, robot assistance results in fewer adjustments, even for seasoned interventional radiologists.

Popular artificial sweetener associated with greater risk of heart attack, stroke

The new study, led by a team of Cleveland Clinic specialists, was published in Nature Medicine

Thumbnail

AI competition furthers research on computer-aided detection in breast imaging

For the challenge, eight teams were tasked with developing algorithms capable of achieving high sensitivity for lesion detection on DBT exams.

Medicare money payment physician

Hospitals still facing financial struggles in 2023

Hospital margins were -1% in January 2023, compared to -0.7% in December 2022. 

 

Medtronic, Abbott share late-breaking TAVR data at CRT 2023

Both vendors used the four-day conference as an opportunity to provide key updates about their TAVR valves.

Incoming 2023-2024 American College of Cardiology (ACC) president Hadley Wilson, MD, shares insights on how to create health equity through both ACC programs and hospital grassroots community outreach programs. He outlines four programs his heart hospital is piloting in its community in Charlotte, North Carolina.

How cardiologists can address health disparities in their communities

Incoming 2023-2024 American College of Cardiology president Hadley Wilson, MD, shared insights on how to create health equity through grassroots community outreach programs.

Abbott and the U.S. Food and Drug Administration (FDA) are warning healthcare providers about the potential risk of early structural valve deterioration (SVD) with Abbott’s line of Trifecta bioprosthetic heart valves. This includes the original Trifecta valve and the Trifecta GT, which are both designed to treat disease, damaged or malfunctioning aortic heart valves.

FDA warns that early deterioration is possible with Abbott’s Trifecta heart valves

Early SVD has been reported in these devices, particularly three to four years after implantation. According to the FDA, this has resulted in surgical replacement procedures and transcatheter valve-in-valve interventions. In some cases, the patient died.